Skip to main content

Renger John's Form 4 filing

Cerevel Therapeutics Holdings, Inc. (CERE) · filed Aug 9, 2022

Accession no.
0000899243-22-028190
Filed
Aug 9, 2022
Trade date
Aug 5-8, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.03M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Renger JohnCIK 0001830363Officer (Chief Scientific Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 5, 2022Common StockMOption exerciseAcquired+20,000$3.50+$70,00022,704Direct
Aug 5, 2022Common StockSSaleDisposed−20,000$32.50−$650,0002,704Direct
Aug 8, 2022Common StockMOption exerciseAcquired+10,000$3.50+$35,00012,704Direct
Aug 8, 2022Common StockSSaleDisposed−10,000$37.75−$377,5002,704Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 5, 2022Common StockMOption exerciseDisposed−20,000$0.00$0119,770Direct
Aug 8, 2022Common StockMOption exerciseDisposed−10,000$0.00$0109,770Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)